Strawberry ENTitis lozenge set, 30 lozenges + cola-flavored Bodymax Bodymisie jelly beans, 60pcs
type: Product
sku: 527562
brand: Lek Pharmaceuticals
category: Sănătate
description: Product description The set includes Entitis preparations for children and Bodymax Bodymisie cola-flavored jellies. Entitis lozenges, 30 pieces - Streptococcus salivarius K12 Sequoia What is Entitis? ENTitis lozenges are a dietary supplement for: in the prevention of recurrent ear, nose, and throat (ENT) infections during a viral infection of the nose and/or throat after suffering angina Ear, nose, and throat (ENT) infections are a very common health problem in both children and adults. Often, the first infection is a precursor to a recurring problem. Bacterial infections are particularly dangerous and require antibiotics. Antibiotics destroy the natural, beneficial bacterial flora and weaken the body's immune system. This, in turn, promotes recurrence of infections. The ENTitis product contains the Streptococcus salivarius K12 strain, which was isolated from a child's mouth, and vitamin D, which, among other things, contributes to the proper functioning of the immune system. Entitis 30 tablets - EFFECTS CONFIRMED IN SCIENTIFIC STUDIES 1-4 A tailor-made preparation Contains the probiotic strain Streptococcus salivarius K12, which was isolated from the oral cavity of a child resistant to recurrent ear, nose and throat infections Patented and unique formula This is the world's first oral preparation with Streptococcus salivarius K12, which produces lantibiotics that inhibit the growth of pathogenic microorganisms such as Streptococcus pyogenes and Streptococcus pneumoniae, responsible for ear, nose and throat infections. The effectiveness of ENTitis tablets: the effectiveness of Streptococcus salivarius K12, contained in the ENTitis preparation, has been confirmed by numerous studies.1-4 High acceptance profile: the preparation does not cause side effects and is readily accepted by children. 1. Di Pierro F. et al. Int J General Medicne 2012(5): 991-997 2. Di Pierro F. et al. Drug, Healthcare and Patient Safety 2014 (6): 15-20 3. Hyink et al. Appl Environ Microbiol. 20…
offers: Offer
  price: 20.9
  price currency: RON
  availability: https://schema.org/InStock
  condition: https://schema.org/NewCondition
  seller: liki24.co.uk
  price valid until: 2026-09-01
  valid from: 2026-08-21T05:12:13.615Z